SCHEMBL9528631

SCHEMBL9528631

CCC#Cc1nc(C(=O)CCCC)nn1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 12/20 0.38
AGTR2 P50052 12/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9527159 0.96 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9527172 0.92 AGTR1 (0.34) AGTR1AGTR2
SCHEMBL9531576 0.90 AGTR1 (0.34) AGTR1AGTR2
SCHEMBL9528331 0.87 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL9531045 0.86 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9528264 0.86 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL9528776 0.85 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9528282 0.85 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9529008 0.85 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9528600 0.85 AGTR1 (0.39) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed